Products
15911 Results
| Quick actions | ISIN | UL | Product | Direction | SL | Ref. | Bid | Spread | Ask | Ratio | % day | % week | % month | Issue date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novartis Constant Leverage with ISIN code: CH1423416655 | Novartis | Constant Leverage | Short | ― | 114.72 | 0.042 | 0.003 | 0.045 | 1 | 0.00% | 40.00% | 27.27% | 12 May. 2025 | |
| Novartis Constant Leverage with ISIN code: CH1423416663 | Novartis | Constant Leverage | Short | ― | 114.72 | 0.12 | 0.030 | 0.15 | 1 | -14.29% | 50.00% | 37.93% | 12 May. 2025 | |
| Novartis Constant Leverage with ISIN code: CH1276587255 | Novartis | Constant Leverage | Short | ― | 114.72 | 0.16 | 0.030 | 0.19 | 1 | -11.11% | 6.67% | 6.67% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1276587248 | Novartis | Constant Leverage | Short | ― | 114.72 | 0.029 | 0.003 | 0.032 | 1 | -6.45% | 11.54% | 11.54% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1276587263 | Novartis | Constant Leverage | Short | ― | 114.72 | 0.87 | 0.030 | 0.9 | 1 | 0.00% | 19.18% | 17.57% | 13 Oct. 2023 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1450968487 | Novo Nordisk | Constant Leverage | Long | ― | 235.219 | 0.001 | ― | ― | 1 | -50.00% | -50.00% | -94.74% | 21 Aug. 2025 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1450968479 | Novo Nordisk | Constant Leverage | Long | ― | 235.219 | 0.55 | 0.030 | 0.58 | 1 | -11.29% | -23.61% | -75.98% | 21 Aug. 2025 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1450968495 | Novo Nordisk | Constant Leverage | Long | ― | 235.219 | 0.001 | ― | ― | 1 | 0.00% | 0.00% | 0.00% | 21 Aug. 2025 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1290993042 | Novo Nordisk | Constant Leverage | Long | ― | 235.219 | 0.009 | ― | ― | 1 | 0.00% | 0.00% | 0.00% | 23 Feb. 2024 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1290993299 | Novo Nordisk | Constant Leverage | Long | ― | 235.219 | 0.009 | ― | ― | 1 | 0.00% | 0.00% | 0.00% | 11 Mar. 2024 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1423415707 | Novo Nordisk | Constant Leverage | Short | ― | 235.219 | 0.022 | 0.003 | 0.025 | 1 | 4.76% | 29.41% | 100.00% | 7 May. 2025 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1276587321 | Novo Nordisk | Constant Leverage | Short | ― | 235.219 | 7.63 | 0.090 | 7.72 | 1 | 6.56% | 22.87% | 93.16% | 13 Oct. 2023 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1290993018 | Novo Nordisk | Constant Leverage | Short | ― | 235.219 | 0.32 | 0.030 | 0.35 | 1 | 3.23% | 23.08% | 100.00% | 23 Feb. 2024 | |
| Nvidia Constant Leverage with ISIN code: CH1119068000 | Nvidia | Constant Leverage | Long | ― | 173.562 | 81.07 | 0.180 | 81.25 | 1 | -11.68% | -15.78% | -34.76% | 12 May. 2022 | |
| Nvidia Constant Leverage with ISIN code: CH1217423008 | Nvidia | Constant Leverage | Long | ― | 173.562 | 4.19 | 0.020 | 4.21 | 1 | -17.52% | -23.26% | -51.67% | 4 Nov. 2022 | |
| Nvidia Constant Leverage with ISIN code: CH1246614460 | Nvidia | Constant Leverage | Long | ― | 173.562 | 0.9 | 0.010 | 0.91 | 1 | -17.43% | -23.08% | -51.09% | 3 Feb. 2023 | |
| Nvidia Constant Leverage with ISIN code: CH1290992705 | Nvidia | Constant Leverage | Long | ― | 173.562 | 0.037 | ― | ― | 1 | -9.76% | -15.91% | -42.19% | 5 Feb. 2024 | |
| Nvidia Constant Leverage with ISIN code: CH1346746873 | Nvidia | Constant Leverage | Long | ― | 173.562 | 0.01 | ― | ― | 1 | 0.00% | 0.00% | -9.09% | 30 Sep. 2024 | |
| Nvidia Constant Leverage with ISIN code: CH1362351806 | Nvidia | Constant Leverage | Long | ― | 173.562 | 0.009 | ― | ― | 1 | 0.00% | 0.00% | 0.00% | 3 Dec. 2024 | |
| Nvidia Constant Leverage with ISIN code: CH1423415665 | Nvidia | Constant Leverage | Long | ― | 173.562 | 10.34 | 0.050 | 10.39 | 1 | -23.24% | -30.42% | -66.15% | 7 May. 2025 |
The underlying prices shown are not real-time prices, i.e. they are delayed due to legal requirements of the data provider. As a consequence, the price of the product on a specific underlying may substantially differ from the price of the product that you would expect on the basis of the underlying price displayed.